"Me-Too" Drugs are Lame For Patients


1st-in-Human Therapeutics, Inc. is focused on developing innovative first-in-human therapeutics that resolve unmet clinical needs.


We have an approach that gives us unique access to ~1000 targets. Many of these targets play a key role in initiating and advancing human disease.


We are building a portfolio of therapeutics that will generate authentic value. As a result of our target profile, we expect our therapeutics will have favorable toxicity and efficacy.


We are seeking collaborations that are mutually beneficial. Do you want to work with us to advance therapeutics that will make treatment decisions easier for patients and clinicians?

Let's Talk

1st Human Therapeutics Is Uniquely Positioned To Build Novel Drug Programs